As you wish, @Klue. It's really disappointing to see this downward spiral of selling now play out. Markets always overshoot to the upside/downside and herd action can drive extraordinary pricing (either FOMO to the upside or FEAR to the downside). It is now up to management to deliver on the $6m+ AUD in EBITDA guidance for FY23 and show Mr Market that this business can deliver a long-term, defensible earnings stream as it enters a strong deleveraging profile. Anyone selling now must really need their cash because, at a market cap of c. $22m, the valuation of this company is at rock bottom (NTA).
- Forums
- ASX - By Stock
- HLF
- HLF Chart
HLF Chart, page-215
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLF (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online